Targeting AKT/PKB to improve treatment outcomes for solid tumors. [electronic resource]
Producer: 20200422Description: 111690 p. digitalISSN:- 1873-135X
- 3-Phosphoinositide-Dependent Protein Kinases -- genetics
- Antineoplastic Agents -- therapeutic use
- Clinical Trials as Topic
- DNA Damage
- DNA Repair -- drug effects
- DNA, Neoplasm -- genetics
- Gamma Rays -- therapeutic use
- Gene Expression Regulation, Neoplastic
- Humans
- Isoenzymes -- antagonists & inhibitors
- Molecular Targeted Therapy -- methods
- Neoplasms -- enzymology
- Phosphatidylinositol 3-Kinases -- genetics
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Signal Transduction
- Treatment Outcome
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.